Bright Minds Biosciences股价在2期临床试验取得积极结果后上涨

Investing.com -- Bright Minds Biosciences (NASDAQ:DRUG) 股价上涨5%，此前这家临床阶段生物技术公司宣布其针对癫痫相关疾病患者的BMB-101 2期BREAKTHROUGH试验取得积极的初步结果。

光明思维生物科技公司以每股90美元定价公开发行

纽约 - 光明思维生物科技公司 ( Bright Minds Biosciences Inc.) (NASDAQ:DRUG) (CSE:DRUG) 已将其公开发行的1,945,000股普通股定价为每股90.00美元，预计将筹集约1.7505亿美元的总收益，据公司新闻稿报道。在过去六个月里，该公司股票已上涨258.96%，目前股价为95.98美元，公司市值约为7.04亿美元。
China.org.cn

Researchers launch spider venom drug trial for heart attacks, strokes

SYDNEY, Jan. 8 (Xinhua) -- A potentially life-saving treatment for heart attacks and strokes, derived from the venom of one of the world's deadliest spiders, has entered human trials, researchers in ...
China.org.cn

Drug manufacturing facility dismantled in Afghanistan's Helmand province

KABUL, Jan. 5 (Xinhua) -- Afghan security forces have uncovered and dismantled a drug manufacturing facility in southern Helmand province, arresting 20 individuals in connection with the case, ...